SOPHiA GENETICS President and CEO Ross Muken discusses the use of AI and technology in diagnosing and treating patients, ...

The Broad Institute, Boston Children’s Hospital, and Maine’s Jackson Laboratory announced a collaboration to develop rare ...

Summary: Researchers identified 11 independent genomic risk regions (loci) and 9 specific candidate genes linked to BPD ...

Rare DNA changes are most strongly linked to cognition in early childhood, but the link fades as children age, while common ...

The only lab test to run four prenatal genetic screens simultaneously as early as eight weeks gestation. SALT LAKE CITY, July 21, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (N ...

For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...

Researchers have identified the first evidence of genetic risk factors associated with borderline personality disorder (BPD).

Genetics influences longevity by providing inherited characteristics related to health, but daily habits are also essential ...

On June 4, 2026, SOPHiA GENETICS SA (NASDAQ:SOPH) reported that it signed a Memorandum of Understanding with Memorial Sloan Kettering Cancer Center to form a proposed joint venture aimed at building a ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Myriad Genetics (NASDAQ:MYGN) and its peers.

View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.